{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:34:53Z","timestamp":1783949693678,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00535-018-1434-6","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T12:46:03Z","timestamp":1516711563000},"page":"967-977","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment"],"prefix":"10.1007","volume":"53","author":[{"given":"Hyun Woo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hoon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hui","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyuck","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangwoo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Wan","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Koo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,23]]},"reference":[{"key":"1434_CR1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00535-016-1302-1","volume":"52","author":"K Kubota","year":"2017","unstructured":"Kubota K, Kamisawa T, Okazaki K, et al. Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients. J Gastroenterol. 2017;52:955\u201364.","journal-title":"J Gastroenterol"},{"issue":"Suppl 18","key":"1434_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00535-007-2044-x","volume":"42","author":"S Kawa","year":"2007","unstructured":"Kawa S, Hamano H. Clinical features of autoimmune pancreatitis. J Gastroenterol. 2007;42(Suppl 18):9\u201314.","journal-title":"J Gastroenterol"},{"key":"1434_CR3","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1572-0241.2004.04162.x","volume":"99","author":"M Takayama","year":"2004","unstructured":"Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol. 2004;99:932\u20137.","journal-title":"Am J Gastroenterol"},{"key":"1434_CR4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gutjnl-2012-304224","volume":"62","author":"T Kamisawa","year":"2013","unstructured":"Kamisawa T, Chari ST, Lerch MM, et al. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut. 2013;62:1373\u201380.","journal-title":"Gut"},{"key":"1434_CR5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.gastro.2010.03.054","volume":"139","author":"RP Sah","year":"2010","unstructured":"Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139:140\u20138 (quiz e12\u20133).","journal-title":"Gastroenterology"},{"key":"1434_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ajg.2010.314","volume":"106","author":"F Maire","year":"2011","unstructured":"Maire F, Le Baleur Y, Rebours V, et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol. 2011;106:151\u20136.","journal-title":"Am J Gastroenterol"},{"key":"1434_CR7","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2008.172908","volume":"58","author":"T Kamisawa","year":"2009","unstructured":"Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504\u20137.","journal-title":"Gut"},{"key":"1434_CR8","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62:1771\u20136.","journal-title":"Gut"},{"key":"1434_CR9","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1038\/ajg.2009.327","volume":"104","author":"L Frulloni","year":"2009","unstructured":"Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009;104:2288\u201394.","journal-title":"Am J Gastroenterol"},{"key":"1434_CR10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajg.2016.40","volume":"111","author":"EL Culver","year":"2016","unstructured":"Culver EL, Sadler R, Simpson D, et al. Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort. Am J Gastroenterol. 2016;111:733\u201343.","journal-title":"Am J Gastroenterol"},{"key":"1434_CR11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/MPA.0000000000000451","volume":"44","author":"J Buijs","year":"2015","unstructured":"Buijs J, Cahen DL, van Heerde MJ, et al. The long-term impact of autoimmune pancreatitis on pancreatic function, quality of life, and life expectancy. Pancreas. 2015;44:1065\u201371.","journal-title":"Pancreas"},{"key":"1434_CR12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/j.gastro.2007.11.023","volume":"134","author":"H Park do","year":"2008","unstructured":"do Park H, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology. 2008;134:440\u20136.","journal-title":"Gastroenterology"},{"key":"1434_CR13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","volume":"40","author":"T Shimosegawa","year":"2011","unstructured":"Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352\u20138.","journal-title":"Pancreas"},{"key":"1434_CR14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/j.gastro.2007.12.014","volume":"134","author":"ST Chari","year":"2008","unstructured":"Chari ST, Murray JA. Autoimmune pancreatitis. Part II: the relapse. Gastroenterology. 2008;134:625\u20138.","journal-title":"Gastroenterology"},{"key":"1434_CR15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00535-014-0945-z","volume":"49","author":"T Kamisawa","year":"2014","unstructured":"Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961\u201370.","journal-title":"J Gastroenterol"},{"key":"1434_CR16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1750-1172-9-77","volume":"9","author":"M Maruyama","year":"2014","unstructured":"Maruyama M, Watanabe T, Kanai K, et al. Autoimmune pancreatitis can develop into chronic pancreatitis. Orphanet J Rare Dis. 2014;9:77.","journal-title":"Orphanet J Rare Dis"},{"key":"1434_CR17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00428-004-1140-z","volume":"445","author":"G Zamboni","year":"2004","unstructured":"Zamboni G, L\u00fcttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445:552\u201363.","journal-title":"Virchows Arch"},{"key":"1434_CR18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.cgh.2009.03.021","volume":"7","author":"NS Sandanayake","year":"2009","unstructured":"Sandanayake NS, Church NI, Chapman MH, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis\/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2009;7:1089\u201396.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1434_CR19","first-page":"1730","volume":"59","author":"M-H Kim","year":"2010","unstructured":"Kim M-H, Moon S-H. The need for a consensus on the definition of remission of autoimmune pancreatitis after steroid treatment. Gut. 2010;59:1730.","journal-title":"Gut"},{"key":"1434_CR20","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1440-1746.2011.06934.x","volume":"27","author":"TJ Song","year":"2012","unstructured":"Song TJ, Kim JH, Kim MH, et al. Comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis. J Gastroenterol Hepatol. 2012;27:700\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"1434_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pan.2016.12.003","volume":"17","author":"K Okazaki","year":"2017","unstructured":"Okazaki K, Chari ST, Frulloni L, et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 2017;17:1\u20136.","journal-title":"Pancreatology"},{"key":"1434_CR22","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1136\/gut.2006.115246","volume":"56","author":"K Hirano","year":"2007","unstructured":"Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis without and with corticosteroid treatment. Gut. 2007;56:1719\u201324.","journal-title":"Gut"},{"key":"1434_CR23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.gie.2007.06.059","volume":"66","author":"K Kubota","year":"2007","unstructured":"Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc. 2007;66:1142\u201351.","journal-title":"Gastrointest Endosc"},{"key":"1434_CR24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","volume":"134","author":"A Ghazale","year":"2008","unstructured":"Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706\u201315.","journal-title":"Gastroenterology"},{"key":"1434_CR25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/MPA.0000000000000633","volume":"45","author":"K Shimizu","year":"2016","unstructured":"Shimizu K, Tahara J, Takayama Y, et al. Assessment of the rate of decrease in serum IgG4 level of autoimmune pancreatitis patients in response to initial steroid therapy as a predictor of subsequent relapse. Pancreas. 2016;45:1341\u20136.","journal-title":"Pancreas"},{"key":"1434_CR26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.gastro.2010.03.054","volume":"139","author":"RP Sah","year":"2010","unstructured":"Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139:140\u20138.","journal-title":"Gastroenterology"},{"key":"1434_CR27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2016-312049","volume":"66","author":"A Masamune","year":"2017","unstructured":"Masamune A, Nishimori I, Kikuta K, et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2017;66:487\u201394.","journal-title":"Gut"},{"key":"1434_CR28","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","volume":"344","author":"H Hamano","year":"2001","unstructured":"Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732\u20138.","journal-title":"N Engl J Med"},{"key":"1434_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11894-012-0246-8","volume":"14","author":"RP Sah","year":"2012","unstructured":"Sah RP, Chari ST. Autoimmune pancreatitis: an update on classification, diagnosis, natural history and management. Curr Gastroenterol Rep. 2012;14:95\u2013105.","journal-title":"Curr Gastroenterol Rep"},{"key":"1434_CR30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gie.2009.08.008","volume":"71","author":"K Hirano","year":"2010","unstructured":"Hirano K, Tada M, Isayama H, et al. Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis. Gastrointest Endosc. 2010;71:85\u201390.","journal-title":"Gastrointest Endosc"},{"key":"1434_CR31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.rcl.2015.12.010","volume":"54","author":"VS Katabathina","year":"2016","unstructured":"Katabathina VS, Khalil S, Shin S, et al. Immunoglobulin G4-related disease: recent advances in pathogenesis and imaging findings. Radiol Clin N Am. 2016;54:535\u201351.","journal-title":"Radiol Clin N Am"},{"key":"1434_CR32","first-page":"76","volume":"30","author":"T Nishino","year":"2005","unstructured":"Nishino T, Toki F, Oyama H, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas. 2005;30:76\u201382.","journal-title":"Pancreas"},{"key":"1434_CR33","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/MPA.0000000000000598","volume":"45","author":"K Kanai","year":"2016","unstructured":"Kanai K, Maruyama M, Kameko F, et al. Autoimmune pancreatitis can transform into chronic features similar to advanced chronic pancreatitis with functional insufficiency following severe calcification. Pancreas. 2016;45:1189\u201395.","journal-title":"Pancreas"},{"key":"1434_CR34","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.3748\/wjg.v22.i34.7760","volume":"22","author":"T Ikeura","year":"2016","unstructured":"Ikeura T, Miyoshi H, Shimatani M, et al. Long-term outcomes of autoimmune pancreatitis. World J Gastroenterol. 2016;22:7760\u20136.","journal-title":"World J Gastroenterol"},{"key":"1434_CR35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22:414\u20138.","journal-title":"Mod Rheumatol"},{"key":"1434_CR36","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ajg.2012.465","volume":"108","author":"M Shiokawa","year":"2013","unstructured":"Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013;108:610\u20137.","journal-title":"Am J Gastroenterol"},{"key":"1434_CR37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MPA.0000000000000053","volume":"43","author":"PA Hart","year":"2014","unstructured":"Hart PA, Law RJ, Dierkhising RA, et al. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 2014;43:417\u201321.","journal-title":"Pancreas"},{"key":"1434_CR38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pan.2014.04.029","volume":"14","author":"T Ikeura","year":"2014","unstructured":"Ikeura T, Miyoshi H, Uchida K, et al. Relationship between autoimmune pancreatitis and pancreatic cancer: a single-center experience. Pancreatology. 2014;14:373\u20139.","journal-title":"Pancreatology"},{"key":"1434_CR39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.gastro.2015.03.010","volume":"149","author":"PA Hart","year":"2015","unstructured":"Hart PA, Zen Y, Chari ST. Recent advances in autoimmune pancreatitis. Gastroenterology. 2015;149:39\u201351.","journal-title":"Gastroenterology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-018-1434-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-018-1434-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-018-1434-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T20:56:09Z","timestamp":1531515369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-018-1434-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1007\/s00535-018-1434-6","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]}}}